ロード中...
Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study
INTRODUCTION: To examine the long‐term efficacy and safety of duloxetine in the treatment of Japanese patients with diabetic neuropathic pain, we carried out a 52‐week, randomized, open‐label extension of a 12‐week, double‐blind, placebo‐controlled study. MATERIALS AND METHODS: Japanese adults with...
保存先:
| 出版年: | J Diabetes Investig |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718094/ https://ncbi.nlm.nih.gov/pubmed/26816607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12361 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|